Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Myriad Genetics, Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference, highlighting its leadership in molecular diagnostic testing and precision medicine [1] Company Overview - Myriad Genetics is a leading company in molecular diagnostic testing and precision medicine, focused on improving health and well-being [2] - The company develops molecular tests that assess disease risk and guide treatment decisions, aiming to enhance patient care and reduce healthcare costs [2]